Osaic Holdings
AXSM icon

Osaic Holdings’s Axsome Therapeutics AXSM Stock Holding History

Osaic Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$2.38K – 7410
2024
Q3 		$2.38K Hold
1
– – ﹤0.01% 6544
2024
Q2 		$1.79K Hold
1
– – ﹤0.01% 6641
2024
Q1 		$2.04K Hold
1
– – ﹤0.01% 6462
2023
Q4 		$2.26K Hold
1
– – ﹤0.01% 6497
2023
Q3 		$1.8K Hold
1
– – ﹤0.01% 6666
2023
Q2 		$2.18K Buy
+1
New +$74 ﹤0.01% 6633

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's AXSM Position: Q2 2026 in Review

Osaic Holdings increased its Axsome Therapeutics (AXSM) stake by 186% in Q2 2026, buying an estimated $2.21M and bringing the position to 15,639 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Osaic Holdings first reported a position in AXSM in Q1 2020 and has held it in 26 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Osaic Holdings held 15,639 shares of Axsome Therapeutics worth $3.83M as of Q2 2026.
  • Osaic Holdings bought 10,171 Axsome Therapeutics shares in Q2 2026, an estimated $2.21M.
  • Axsome Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #1750 holding.
  • Osaic Holdings first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.